Clinical Improvements With Setmelanotide in a 2-Year-Old Patient With Hyperphagia and Obesity due to Leptin Receptor Deficiency: A Case Report
Setmelanotide treatment started in a 2-year-old patient and continued for 23 months led to reductions in hyperphagia and food-seeking behavior, as well as improved motor skill function, BMI, and blood lipids. These findings support the use of setmelanotide in young children with hyperphagia and obesity due to LEPR deficiency.
Authors
- Marina Gutiérrez Vilar
- Mónica Ruiz Pons
- Javier Merino Alonso
- Alejandra Pérez Rodriguez
Publication Details
- Journal
- Obesity Facts
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1159/000551601
- Primary Topic
- Genetic and Kidney Cyst Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00